Breast cancer is a heterogeneous disease composed of several biological subtypes; for instance, luminal A breast cancer, luminal B breast cancer, human epidermal growth factor receptor 2 (HER2)-enriched breast cancer, triple-negative breast cancer, and normal-like breast cancer (Feng et al., 2018). Here, ERBB2 is linked to breast carcinoma.